(USAC) USA Compression Partners - Ratings and Ratios
Compression, Treating, Cooling, Dehydration, Hp-Fleet
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 9.17% |
| Yield on Cost 5y | 27.85% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 96.9% |
| Payout Ratio | 2.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 27.9% |
| Value at Risk 5%th | 42.4% |
| Relative Tail Risk | -7.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -5.33 |
| CAGR/Max DD | 0.64 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.335 |
| Beta | 0.894 |
| Beta Downside | 1.206 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.35% |
| Mean DD | 9.42% |
| Median DD | 10.08% |
Description: USAC USA Compression Partners November 08, 2025
USA Compression Partners, LP (NYSE: USAC) is a Dallas-based provider of natural-gas compression services across the United States. It serves oil majors, independent producers, midstream processors, gatherers and transporters, and also offers compression for infrastructure projects such as centralized gathering systems, processing plants, and gas-lift applications in crude-oil wells. In addition, the firm operates a fleet that delivers natural-gas treating services-including CO₂ and H₂S removal, cooling, and dehydration-for producers and midstream operators. As of 31 December 2024 the company’s fleet totals 3,862,102 horsepower.
Key industry metrics that influence USAC’s outlook include: (1) U.S. dry-gas production, which held steady near 100 billion cubic feet per day in 2023, sustaining strong demand for compression capacity; (2) compression unit utilization, historically averaging 78-82 % in the mid-stream sector, a proxy for pricing power; and (3) ESG-driven growth in gas-treating services, where CO₂ removal volumes have risen ~12 % YoY as producers seek to meet stricter emissions standards. The company’s EBITDA margin typically hovers around 30 % and its leverage ratio (net debt/EBITDA) has been trending lower, reflecting a balance sheet that can support incremental fleet expansion.
For a deeper dive into USAC’s valuation dynamics and how its exposure to natural-gas compression trends compares with peers, you may find ValueRay’s analytical tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (114.9m TTM) > 0 and > 6% of Revenue (6% = 59.5m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 7.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6.74% (prev 8.52%; Δ -1.79pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 336.6m > Net Income 114.9m (YES >=105%, WARN >=100%) |
| Net Debt (2.53b) to EBITDA (454.5m) ratio: 5.56 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.36 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (122.7m) change vs 12m ago 3.75% (target <= -2.0% for YES) |
| Gross Margin 61.64% (prev 67.24%; Δ -5.61pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 36.30% (prev 33.16%; Δ 3.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.29 (EBITDA TTM 454.5m / Interest Expense TTM 190.1m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 67.19
| 1. Piotroski 5.0pt |
| 2. FCF Yield 4.50% |
| 3. FCF Margin 24.33% |
| 4. Debt/Equity 90.78 |
| 5. Debt/Ebitda 5.56 |
| 6. ROIC - WACC (= 3.42)% |
| 7. RoE -754.2% |
| 8. Rev. Trend 97.15% |
| 9. EPS Trend 95.91% |
What is the price of USAC shares?
Over the past week, the price has changed by +1.10%, over one month by -9.02%, over three months by -3.24% and over the past year by +8.31%.
Is USAC a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 4
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the USAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.8 | 17.2% |
| Analysts Target Price | 26.8 | 17.2% |
| ValueRay Target Price | 27.7 | 20.8% |
USAC Fundamental Data Overview December 27, 2025
P/E Trailing = 28.5309
P/E Forward = 16.5017
P/S = 2.8595
P/B = 24.8274
P/EG = -68.32
Beta = 0.225
Revenue TTM = 991.6m USD
EBIT TTM = 244.3m USD
EBITDA TTM = 454.5m USD
Long Term Debt = 2.53b USD (from longTermDebt, last quarter)
Short Term Debt = 4.39m USD (from shortTermDebt, last fiscal year)
Debt = 2.52b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 2.53b USD (from netDebt column, last quarter)
Enterprise Value = 5.35b USD (2.84b + Debt 2.52b - CCE 14.0k)
Interest Coverage Ratio = 1.29 (Ebit TTM 244.3m / Interest Expense TTM 190.1m)
FCF Yield = 4.50% (FCF TTM 241.2m / Enterprise Value 5.35b)
FCF Margin = 24.33% (FCF TTM 241.2m / Revenue TTM 991.6m)
Net Margin = 11.59% (Net Income TTM 114.9m / Revenue TTM 991.6m)
Gross Margin = 61.64% ((Revenue TTM 991.6m - Cost of Revenue TTM 380.4m) / Revenue TTM)
Gross Margin QoQ = 40.79% (prev 69.25%)
Tobins Q-Ratio = 2.01 (Enterprise Value 5.35b / Total Assets 2.66b)
Interest Expense / Debt = 1.87% (Interest Expense 47.1m / Debt 2.52b)
Taxrate = 6.52% (2.41m / 36.9m)
NOPAT = 228.4m (EBIT 244.3m * (1 - 6.52%))
Current Ratio = 1.36 (Total Current Assets 251.6m / Total Current Liabilities 184.8m)
Debt / Equity = 90.78 (Debt 2.52b / totalStockholderEquity, last fiscal year 27.8m)
Debt / EBITDA = 5.56 (Net Debt 2.53b / EBITDA 454.5m)
Debt / FCF = 10.49 (Net Debt 2.53b / FCF TTM 241.2m)
Total Stockholder Equity = -15.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.32% (Net Income 114.9m / Total Assets 2.66b)
RoE = -754.2% (negative equity) (Net Income TTM 114.9m / Total Stockholder Equity -15.2m)
RoCE = 9.72% (EBIT 244.3m / Capital Employed (Equity -15.2m + L.T.Debt 2.53b))
RoIC = 9.17% (NOPAT 228.4m / Invested Capital 2.49b)
WACC = 5.75% (E(2.84b)/V(5.36b) * Re(9.31%) + D(2.52b)/V(5.36b) * Rd(1.87%) * (1-Tc(0.07)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.18%
[DCF Debug] Terminal Value 64.94% ; FCFE base≈163.7m ; Y1≈107.5m ; Y5≈49.2m
Fair Price DCF = 6.45 (DCF Value 791.6m / Shares Outstanding 122.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 95.91 | EPS CAGR: 165.6% | SUE: 0.61 | # QB: 0
Revenue Correlation: 97.15 | Revenue CAGR: 12.68% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.39 | Chg30d=+0.095 | Revisions Net=+2 | Analysts=2
EPS next Year (2026-12-31): EPS=1.32 | Chg30d=+0.020 | Revisions Net=+0 | Growth EPS=+31.7% | Growth Revenue=+15.7%
Additional Sources for USAC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle